Prophylactic aspirin and risk of peptic ulcer bleeding. - Wikidata - awgldk - TriplyDB

Prophylactic aspirin and risk of peptic ulcer bleeding.

Prophylactic aspirin and risk of peptic ulcer bleeding.

http://www.wikidata.org/entity/Q41848139

about

The risk of upper gastrointestinal complications associated with nonsteroidal anti-inflammatory drugs, glucocorticoids, acetaminophen, and combinations of these agents.Aspirin in the Chemoprevention of Colorectal Neoplasia: An Overview A turbulent decade for NSAIDs: update on current concepts of classification, epidemiology, comparative efficacy, and toxicity Risk of upper gastrointestinal bleeding and perforation associated with low-dose aspirin as plain and enteric-coated formulations COX-2: where are we in 2003?--distinction from NSAIDs becoming blurred Aspirin for primary prevention of cardiovascular disease Adverse drug reactions and drug-drug interactions with over-the-counter NSAIDs Restoring psychology's role in peptic ulcer Gastrointestinal ulcers, role of aspirin, and clinical outcomes: pathobiology, diagnosis, and treatment Guidelines for the appropriate use of non-steroidal anti-inflammatory drugs, cyclo-oxygenase-2-specific inhibitors and proton pump inhibitors in patients requiring chronic anti-inflammatory therapy Cardiovascular prophylaxis with aspirin: costs of supply and management of upper gastrointestinal and renal toxicity Effects of buffered and plain acetylsalicylic acid formulations with and without ascorbic acid on gastric mucosa in healthy subjects Concomitant use of buffered and enteric-coated low-dose aspirin products and antisecretory drugs NSAIDs: gastroprotection or selective COX-2 inhibitor?Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients Minimizing complications from nonsteroidal antiinflammatory drugs: cost-effectiveness of competing strategies in varying risk groups Non-steroidal anti-inflammatory drugs and gastrointestinal damage-problems and solutions Aspirin for primary prevention of coronary heart disease: safety and absolute benefit related to coronary risk derived from meta-analysis of randomised trials A comparison of every-third-day versus daily low-dose aspirin therapy on serum thromboxane concentrations in healthy men and women Aspirin under fire: aspirin use in the primary prevention of coronary heart disease Effect of nonsteroidal anti-inflammatory drug use on the rate of gastrointestinal hospitalizations among people living in long-term care Ulcer complications associated with anti-inflammatory drug use. What is the extent of the disease burden?Helicobacter pylori infection as a risk factor for gastrointestinal symptoms in patients using aspirin to prevent ischaemic heart disease Long-term use of aspirin and nonsteroidal anti-inflammatory drugs and risk of colorectal cancer Association between aspirin and upper gastrointestinal complications: systematic review of epidemiologic studies Risk of gastric injury with enteric- versus nonenteric-coated aspirin Upper gastrointestinal bleeding among users of NSAIDs: a population-based cohort study in Denmark Interactions between Helicobacter pylori and other risk factors for peptic ulcer bleeding Helicobacter pylori increases the risk of upper gastrointestinal bleeding in patients taking low-dose aspirin Prevalence and incidence of gastroduodenal ulcers during treatment with vascular protective doses of aspirin Management of peptic ulcer disease not related to Helicobacter An update on nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 inhibitors Gastrointestinal tolerability of ibuprofen compared with paracetamol and aspirin at over-the-counter doses Upper gastrointestinal haemorrhage complicating antiplatelet treatment with aspirin and/or clopidogrel: where we are now?Hospitalization and mortality rates from peptic ulcer disease and GI bleeding in the 1990s: relationship to sales of nonsteroidal anti-inflammatory drugs and acid suppression medications Risk of upper gastrointestinal bleeding in patients taking low-dose aspirin for the prevention of cardiovascular diseases Upper gastrointestinal bleeding associated with antiplatelet drugs Antithrombotic therapy for congestive heart failure Upper gastrointestinal mucosal abnormalities and blood loss complicating low-dose aspirin and antithrombotic therapy Primary care physician perceptions of non-steroidal anti-inflammatory drug and aspirin-associated toxicity: results of a national survey

P2860

Q21195670-73E44157-7903-49BE-8818-2F39C88E6758 Q22306433-6D110A12-4947-4A08-B2AC-B4D6D9329B0D Q24615651-4AB45450-0EEE-4F2D-A891-D4C34C689292 Q24798492-8F592B59-1A94-42CC-A0C6-E96A17BF1566 Q24804373-8D6BE61C-FB7B-4EEB-B348-7BAD2FD6C915 Q26774150-0B8BE381-E590-4363-83FF-C261E7B2FB81 Q26800279-E5663BE6-3B71-4AFD-8596-04CDED68834F Q26865361-2E081ED2-D83F-4EEB-8FA0-779A77EAA9F6 Q27027977-6CFB4482-CBBC-4739-8882-5D9BF306B173 Q28166768-2F81AB9D-7B75-4F74-B408-7332E3D432BE Q28166985-8354BC5F-AC14-4BBD-977C-903A39BF8626 Q28167440-A9B40A57-0587-4F68-815D-FA58977B552B Q28168123-9C2FF1BC-7B9E-433E-98EB-3BAE446AECC1 Q28168965-E7C0056F-5899-491C-A27D-201BC0D760DF Q28169189-9A7DC78A-50E2-4C54-861C-D17816A6ECFA Q28173947-B19F3082-6CEC-4791-A473-8B673F094CA8 Q28175347-2B0AF5FF-04F0-4938-A406-1DDFFCEAD124 Q28175861-5BA644FA-24F8-4797-A76C-1AF7821B7DC9 Q28176072-5F0AC2C1-CFD0-40A0-9979-A00E3979B275 Q28176243-DC411BC1-8322-48D3-82B4-A51CBBA9463A Q28184371-BAB7B095-DBA3-4C17-BF10-B040282121D8 Q28185419-FCDBA4D3-BF1A-4A02-8C36-50180EC82CEA Q28185607-0D4ABBA4-53FB-4543-9553-C6A940AC19FB Q28188848-B6267D41-8217-4FAA-AC7A-2AC9163FA3D6 Q28191843-10C4482D-4A58-4CAE-95CA-09948456E0FF Q28192241-87BCD9D6-1945-4A9D-9C88-A2D4ACD85233 Q28192383-B9B02A54-F14B-4754-ACBB-1B92D26C0D5B Q28192471-6440FD4E-7CC7-4A6A-818D-83DD98E135DB Q28192693-A5720E36-EDA5-4C1E-A4D7-CCC0EC85B001 Q28192701-DB3C731A-5B1A-455A-BBC1-FA726AE1CC3A Q28192901-46131118-23E0-4101-B82D-6AA28EC25CA6 Q28193309-DCE1FF36-2DBB-474C-8155-7F136215E9AD Q28193558-24FB9A68-1B3C-4097-A0A7-0E11CECDC658 Q28193564-18FCDE2C-B38D-4C6C-81FE-8159C5592C95 Q28193963-D4986035-26E5-4BB0-96EE-3019A30BF780 Q28193996-7F91C16B-6941-4597-82FD-C10A275A1F77 Q28194354-FB795D17-73FF-48CA-A0E3-12FE23BDAD25 Q28194472-E93506AD-02EC-44C0-9444-ECFAB55E06EF Q28194669-8873CEC6-CC61-464E-A5A2-36D959868690 Q28195079-116A9F3E-3358-4C4B-B55C-DA9C969C02A2

P2860

Prophylactic aspirin and risk of peptic ulcer bleeding.

http://www.wikidata.org/entity/Q41848139

description

1995 nî lūn-bûn

@nan

1995年の論文

@ja

1995年論文

@yue

1995年論文

@zh-hant

1995年論文

@zh-hk

1995年論文

@zh-mo

1995年論文

@zh-tw

1995年论文

@wuu

1995年论文

@zh

1995年论文

@zh-cn

name

Prophylactic aspirin and risk of peptic ulcer bleeding.

@en

type

label

Prophylactic aspirin and risk of peptic ulcer bleeding.

@en

prefLabel

Prophylactic aspirin and risk of peptic ulcer bleeding.

@en

P1433

Q41848139-03E7CB83-DF6C-48E2-B9BF-D022F657B09A

P1476

Q41848139-C63DFDB9-62BC-4AAE-9FFE-BA3EE3F5D263

P2093

Q41848139-2B14D5A1-DAEC-4B79-B1AE-AA13FECE44BC

Q41848139-404C2FA1-8955-4892-9DB4-5D5278EDAE3D

Q41848139-4D9B18EE-D222-47EA-8DA9-687251FA4008

Q41848139-66E4375F-E730-4BC2-BD5A-2D94D960A947

Q41848139-674BF246-7EB5-43BB-91F7-4D809AC42CF6

Q41848139-C7D5667D-18AA-4296-9D41-E759F8AA1A8C

Q41848139-EF5E16FD-860C-48B2-8F42-659F1FCF3445

Q41848139-F74A2E84-9373-4571-A8B4-CE88FC9294A3

Q41848139-FD668405-0878-4041-BB03-B06E57FA4C28

P2860

Q41848139-3701FDB3-FBA7-4E09-95F5-D9281848B3A6

Q41848139-3F662762-3A13-4CEE-B5A6-B2065DDF9F6F

Q41848139-4A369FB3-393D-4606-BE7A-BA61636AF965

Q41848139-5174D059-2ECE-433B-BAD9-B94AEF407312

Q41848139-5E87ECFC-7B53-471A-A1BF-729F57CB6B26

Q41848139-6AC9513A-64DD-47A4-8696-452F45913431

Q41848139-A04F1020-1F95-4058-ABCD-ADEA27DDEC40

Q41848139-C30E180A-84A7-4836-A66F-518033C9A59C

Q41848139-CDD3D201-365C-43B1-BC1C-40E90CC72230

Q41848139-E91F6BA2-C6DC-456F-B28E-F44F4D58AF69

P304

Q41848139-F808CF91-85A4-4C22-A80C-341057D6E0A7

P31

Q41848139-D81E09A4-2C35-403A-BF5A-F9C0A0C6E7E2

P356

Q41848139-E0DF56AA-5290-4011-8D62-BF9AAC4E23A7

P407

Q41848139-5D5DFC9B-0EF5-4355-95F9-8872ACA12EB6

P433

Q41848139-62E6DDEC-5DEB-4438-963E-361FF2DA0CC3

P478

Q41848139-867289F6-6C5A-40C0-BF6E-8964F8CFB926

P577

Q41848139-C73FC0FB-308A-48A4-98A0-7FBF32FECE8D

P5875

Q41848139-AB7EB539-4A94-4421-9D2D-12376813A9AF

P698

Q41848139-B5DD891D-870A-4DD5-9631-9A0B5B03DB35

P932

Q41848139-019BEDC8-169F-4EA5-81FF-1BFC7695B23F

P356

BMJ.310.6983.827

P1433

P1476

Prophylactic aspirin and risk of peptic ulcer bleeding.

@en

P2093

Colin-Jones D

http://www.w3.org/2001/XMLSchema#string

Langman M

http://www.w3.org/2001/XMLSchema#string

Lawson D

http://www.w3.org/2001/XMLSchema#string

Logan R

http://www.w3.org/2001/XMLSchema#string

Murphy M

http://www.w3.org/2001/XMLSchema#string

Rawlins M

http://www.w3.org/2001/XMLSchema#string

Vessey M

http://www.w3.org/2001/XMLSchema#string

Wainwright P

http://www.w3.org/2001/XMLSchema#string

Weil J

http://www.w3.org/2001/XMLSchema#string

P2860

A randomized controlled trial of acetyl salicylic acid in the secondary prevention of mortality from myocardial infarction

The gastrointestinal toxicity of aspirin: an overview of randomised controlled trials.

Use of anti-inflammatory drugs by patients admitted with small or large bowel perforations and haemorrhage.

Aspirin, paracetamol, and haematemesis and melaena

Aspirin and bleeding peptic ulcers in the elderly.

Aspirin and secondary mortality after myocardial infarction.

Human gastric mucosal bleeding induced by low dose aspirin, but not warfarin.

Aspirin, sulfinpyrazone, or both in unstable angina. Results of a Canadian multicenter trial.

Acetylsalicylic acid in the prevention of stroke in patients with reversible cerebral ischemic attacks. A Danish cooperative study.

Extra-cranial bleeding and other symptoms due to low dose aspirin and low intensity oral anticoagulation.

P304

827-830

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/BMJ.310.6983.827

http://www.w3.org/2001/XMLSchema#string

P407

P433

6983

http://www.w3.org/2001/XMLSchema#string

P478

310

http://www.w3.org/2001/XMLSchema#string

P577

1995-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

232268181

http://www.w3.org/2001/XMLSchema#string

P698

7711618

http://www.w3.org/2001/XMLSchema#string

P932

2549215

http://www.w3.org/2001/XMLSchema#string